Skip to content

Optimizing Indocyanine Green (ICG) Dosage to Enhance Fluorescence Imaging in Laparoscopic Cholecystectomy: A Comparative Analysis

The application of indocyanine green fOptimizing Indocyanine Green (ICG) Dosage to Enhance Fluorescence Imaging in Laparoscopic Cholecystectomy: A Comparative Analysisluorescence imaging technology in the minimally invasive treatment of benign bili

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100138
Enrollment
Unknown
Registered
2025-04-03
Start date
2024-01-21
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign gallbladder disease

Interventions

Sponsors

Shijiazhuang People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Participants should be adults aged 18-80 years with complete clinical data and must have provided informed consent by signing an informed concent form; 2.The preoperative diagnosis of benign gallbladder disease should be established based on thorough medical history, physical examination, and at least one auxiliary diagnostic imaging procedure (abdominal ultrasound, CT, or MRI); 3.Eligibility for LC; 4.Child-Pugh classification of Grade A; 5. Patients should not have undergone any other abdominal surgical procedures during the current hospitalization period.

Exclusion criteria

Exclusion criteria: 1.History of allergy to iodine or indocyanine green; 2. Liver function classified as Child-Pugh Grade B or C; 3. Patients with severe coagulation disorders or poor cardiopulmonary function who are unable to tolerate surgery or anesthesia; 4.Biliary obstruction or bile metabolism disorders; 5.Presence of malignant tumors in the gallbladder or liver.

Design outcomes

Primary

MeasureTime frame
Fluorescence intensity ratio;Evaluation data of imaging effect of biliary system;Intraoperative determination of bile duct time;Blood loss;

Secondary

MeasureTime frame
First exhaust time after surgery;WBC count;

Countries

China

Contacts

Public ContactJianbin Gu

Shijiazhuang People’s Hospital

2908270202@qq.com+86 176 0311 3060

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026